Abstract Objective To study the effect and safety of intensive phototherapy in the treatment of neonatal hyperbilirubinemia. Methods A total of 144 neonates with neonatal hyperbilirubinemia were randomly and prospectively divided into intensive phototherapy group and conventional phototherapy group, with 72 neonates in each group. The therapeutic effect and incidence of complications were compared between the two groups. Results Within 12 hours after phototherapy, the total serum bilirubin level in the intensive phototherapy group was significantly lower than in the conventional phototherapy group (PPPConclusions During the initial stage of phototherapy, intensive phototherapy can quickly and effectively reduce the serum level of bilirubin in neonates with neonatal hyperbilirubinemia. It can also shorten the total phototherapy time, and does not increase the incidence of adverse events. Therefore, it is superior to conventional phototherapy.
ZHANG Xiao-Rui,ZENG Chao-Mei,LIU Jie. Effect and safety of intensive phototherapy in treatment of neonatal hyperbilirubinemia[J]. CJCP, 2016, 18(3): 195-200.
ZHANG Xiao-Rui,ZENG Chao-Mei,LIU Jie. Effect and safety of intensive phototherapy in treatment of neonatal hyperbilirubinemia[J]. CJCP, 2016, 18(3): 195-200.
Bhutani VK, Stark AR, Lazzeroni LC, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy [J]. J Pediatr, 2013, 162(3): 477-482.
[2]
Slusher TM, Zipursky A, Bhutani VK. A global need for affordable neonatal jaundice technologies[J]. Semin Perinatol, 2011, 35(3): 185-191.
[3]
Hameed NN, Na'Ma AM, Vilms R, et al. Severe neonatal hyperbilirubinemia and adverse short-term consequences in Baghdad, Iraq [J]. Neonatology, 2011, 100(1): 57-63.
[4]
Amer ican Academy of Pediatr ics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [J]. Pediatrics, 2004, 114(1): 297-316.
[5]
Kale Y, Aydemir O, Celik Ü, et al. Effects of phototherapy using different light sources on oxidant and antioxidant status of neonates with jaundice[J]. Early Hum Dev, 2013, 89(12): 957-960.
[6]
Gamaleldin R, Iskander I, Seoud I, et al. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia[J]. Pediatrics, 2011, 128 (4): e925-e931.
[7]
Mwaniki MK, Atieno M, Lawn JE, et al. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review [J]. Lancet, 2012, 379(9814): 445-452.
[8]
Wallenstein MB, Bbutani VK. Jaundice and kernicterus in the moderately preterm infant [J]. Clin Perinatal, 2013, 40(4): 679-688.
[9]
Tatli MM, Minnet C, Kocyigit A, et al. Phototherapy increase DNA damage in lymphocytes of hyperbilirubinemic neonates[J]. Mutat Res, 2008, 654(1): 93-95.
Kumar P, Murki S, Malik GK, et al. Light emitting diodes versus compact fluorescent tubes for phototherapy in neonatal jaundice: a multi-center randomized controlled trial[J]. Indian Pediatr, 2010, 47(2): 131-137.
Hooman N, Honarpisheh A. The effect of phototherapy on urinary calcium excretion in newborns[J]. Pediatr Nephrol, 2005, 20(9): 1363-1364.
[16]
Gómez-Meda BC, Barros-Hernández A, Guzmán-Bárcenas J, et al. Effects of blue light phototherapy on DNA integrity in preterm newborns[J]. J Photochem Photobiol B, 2014, 141: 283-287.
[17]
Ramy N, Ghany EA, Alsharany W, et al. Jaundice, phototherapy and DNA damage in full-term neonates[J]. J Perinatol, 2016, 36(2): 132-136.
[18]
Kahveci H, Dogan H, Karaman A, et al. Phototherapy causes a transient DNA damage in jaundiced newborns[J]. Drug Chem Toxicol, 2013, 36(1): 88-92.